Deborah H. Charych - 01 Mar 2023 Form 3/A - Amendment Insider Report for Skye Bioscience, Inc. (SKYE)

Role: Director
Signature: /s/ Kaitlyn Arsenault, as Attorney-in-Fact
Issuer symbol: SKYE
Transactions as of: 01 Mar 2023
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 03 Mar 2023, 11:05:32 UTC
Date Of Original Report: 16 Feb 2023
Previous filing: 16 Feb 2023
Next filing: 29 Aug 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

(1) Dr. Charych's appointment to the Board of Directors (the "Board") of Skye Bioscience, Inc. was approved by the Board on February 14, 2023, however such appointment was not effective until March 1, 2023. Accordingly, this Form 3/A is being filed to reflect the effective date of her appointment. (2) Exhibit 24 - Power of Attorney (previously filed).